Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01579370 · ClinicalTrials.gov registry record · NA
Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)
A NA study of Healthcare Associated Infections and Multidrug Resistant Organisms, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 21,395
- Enrollment target
- 9
- Study locations
NCT01579370 is a NA study of Healthcare Associated Infections and Multidrug Resistant Organisms that has completed, run by Duke University. The registered enrollment target is 21,395 participants. The trial reports 9 study locations across 2 states.
The verdict
NCT01579370, a NA study of Healthcare Associated Infections and Multidrug Resistant Organisms, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 21,395 participants
- Enrollment target
- 9
- Study locations
Study Summary
Enhanced terminal room disinfection is a novel, promising, but still unproven strategy for the prevention of healthcare-associated infections (HAIs) due to selected multidrug-resistant (MDR) bacterial pathogens. The investigators will perform a large prospective, multicenter study enhanced terminal room disinfection to 1) determine the efficacy and feasibility of enhanced terminal room disinfection strategies to prevent HAIs and 2) determine the impact of environmental contamination on acquisition of MDR-pathogens among hospitalized patients.
Conditions Studied
Interventions
- OTHER Quaternary ammonium
- OTHER Bleach
- OTHER Quaternary ammonium and UV-C light
- OTHER Bleach and UV-C light
Study Locations (9)
North Carolina
- Alamance Regional Medical Center - Burlington
- University of North Carolina Hospitals - Chapel Hill
- Durham Regional Hospital - Durham
- Duke University Medical Center - Durham
- Durham VA Medical Center - Durham
- High Point Regional Health System - High Point
- Rex Healthcare - Raleigh
- Duke Raleigh Hospital - Raleigh
Virginia
- Chesapeake Regional Medical Center - Chesapeake
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21,395 participants |
| Start Date | 2012-04 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01579370
The ClinicalTrials.gov registry entry for NCT01579370 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21,395 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Healthcare Associated Infections appearing as the primary indexed condition, and to 4 interventions - of which Quaternary ammonium is the first listed.
NCT01579370 reports 9 study locations spanning 2 distinct geographic areas - top geographies include North Carolina, Virginia.
Frequently Asked Questions
What is clinical trial NCT01579370 about?
NCT01579370 is a clinical study titled "Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)". Enhanced terminal room disinfection is a novel, promising, but still unproven strategy for the prevention of healthcare-associated infections (HAIs) due to selected multidrug-resistant (MDR) bacterial pathogens. The investigators will perform a large prospective, multicenter study enhanced terminal ...
What is the current status of trial NCT01579370?
This trial is currently completed. It is a NA study. The enrollment target is 21,395 participants. The study started on 2012-04. Estimated completion is 2015-08.
What conditions does trial NCT01579370 study?
This clinical trial studies the following conditions: Healthcare Associated Infections, Multidrug Resistant Organisms.
What interventions are being tested in trial NCT01579370?
The interventions under investigation include: Quaternary ammonium (OTHER), Bleach (OTHER), Quaternary ammonium and UV-C light (OTHER), Bleach and UV-C light (OTHER).
Who is sponsoring clinical trial NCT01579370?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01579370 being conducted?
This trial has 9 study locations across North Carolina, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthcare Associated Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Healthcare Associated Infections
All registered trials for this condition
Multidrug Resistant Organisms
All registered trials for this condition
North Carolina
All trials with a study site in North Carolina
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.